Medigene AG
MDG1 | F
Overview
Corporate Details
- ISIN(s):
- DE000A40ESG2
- LEI:
- 391200I33JD2DKZGDX06
- Country:
- Germany
- Address:
- Lochhamer Straße 11, 82152 Planegg
- Website:
- https://medigene.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Medigene AG (FWB: MDG1) is a publicly listed, immuno-oncology platform company dedicated to developing t cell receptor (tcr)-guided therapies to effectively eliminate cancer Generation of optimal affinity 3S (specificity, sensitivity, and safety ) TCRs is the foundation for our integrated proprietary End-to-End Platform which includes multiple TCR generation and optimization technologies as well as product enhancement technologies. These 3S- TCRs show great potential for application across various modalities, including TCR-T cell engagers, as well as TCR-natural killer cell therapies and TCR-T therapies.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Ascelia Pharma | Sweden | ACE | |
|
Atrys Health S.A. | Spain | ATRY | |
|
AUKETT SWANKE GROUP PLC | United Kingdom | AUK | |
|
Azorean - Aquatic Technologies S.A. | Portugal | MLAAT | |
|
Bachem Holding AG | Switzerland | BANB | |
|
Bavarian Nordic | Denmark | BAVA | |
|
BB Biotech AG | Switzerland | BION | |
|
BEEKS FINANCIAL CLOUD GROUP PLC | United Kingdom | BKS | |
|
BenevolentAI | United Kingdom | BAI | |
|
BerGenBio | Norway | BGBIO |